Central neuron-glia interactions and neuropathic pain
Overview of recent concepts and clinical implications
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Neuropathic pain results from injury or disease causing dysfunction at any level of the somatosensory (primarily spinothalamic) system, including peripheral nociceptive axons, dorsal root ganglion (DRG), dorsal horn, spinothalamic pathway, and thalamus. The manifestations of neuropathic pain, including spontaneous pain, hyperalgesia, and thermal and mechanical allodynia, reflect excessive excitability of peripheral nociceptors (peripheral sensitization), central nociceptive neurons (central sensitization), or both. Sensitization reflects maladaptive plastic changes in the nociceptive system that result directly from axonal injury and from the effects of products of inflammation. There is abundant evidence that activation of microglia and astrocytes in the dorsal horn is common and constitutes an important amplification mechanism leading to neuropathic pain in the setting of peripheral nerve or spinal cord injury. Activated glial cells are also involved in sensitization of brainstem and thalamic neurons at a distance from the site of injury. The complex roles of the central glia and its mediators in the mechanisms of neuropathic pain have been extensively reviewed.1–9
NORMAL PAIN SIGNALING PAIN PROCESSING
The components of transmission of nociceptive information (“pain system”) include the nociceptive neurons of the DRG with unmyelinated C- and small myelinated Aδ axons that activate different types of neurons in the dorsal horn, particularly in lamina I and lamina V, which project via parallel pathways to the thalamus and to the brainstem. The primary DRG afferents also activate excitatory and inhibitory interneurons in lamina II that exert local control on nociceptive transmission.10–12 Similar organization occurs in the nociceptive trigeminal system. The nociceptive DRG neurons express different types of voltage-gated sodium (Na+) channels (particularly Nav1.7, Nav1.8, and Nav1.9), transient receptor potential (TRP) channels (including TRPV1 and TRPA), acid-sensitive channels, serotonin 5-HT3 receptors, and purinergic P2X receptors that are activated by noxious mechanical or chemical stimuli.11 In normal conditions, activation of Aδ and C-fiber nociceptors leads …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Rituximab Therapy in the Treatment of Juvenile Myasthenia Gravis: The French Experience
Dr. Henry J. Kaminski and Dr. Sarah Wright
► Watch
Related Articles
- No related articles found.
Alert Me
Recommended articles
-
Clinical Implications of Neuroscience Research
Ion channels in nociceptorsRecent developmentsEduardo E. Benarroch et al.Neurology, February 20, 2015 -
Clinical Implications of Neuroscience Research
Dorsal horn circuitryComplexity and implications for mechanisms of neuropathic painEduardo E. Benarroch et al.Neurology, February 17, 2016 -
Clinical Implications of Neuroscience Research
CGRPSensory neuropeptide with multiple neurologic implicationsEduardo E. Benarroch et al.Neurology, July 18, 2011 -
Basic Science in the Clinic
What Is the Role of Sphingosine-1-Phosphate Receptors in Pain?Eduardo E. Benarroch et al.Neurology, March 15, 2021